ELVNEnliven Therapeutics Inc. Common Stock
59.82USD+0.72%Mkt Cap: 4.38B $P/E: —3d ago
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its clinical programs comprise ELVN-001, a small…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap4.38B $
Enterprise Value3.42B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-103.69M $
Revenue/Share—
Last Price59.82 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees67
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-25.20
PEG—
EV/EBITDA-27.55
EV/Revenue—
P/S—
P/B4.82
EPS (TTM)-1.64
EPS (Forward)-2.34
52W Range
14.7995% of range62.32
52W High62.32 USD
52W Low14.79 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-22.56%
ROA-21.78%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-70.30M $
CapEx (TTM)158.00K $
FCF Margin—
FCF Yield-1.03%
Net Debt-893.65M $
Net Debt/EBITDA7.19
Balance Sheet
Debt/Equity0.00
Current Ratio64.07
Quick Ratio63.21
Book Value/Sh12.22 USD
Cash/Share12.22 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)73.90 USD
Upside (mean)+23.5%
Target Range64.00 USD – 82.00 USD
$64.00+23.5% to mean$82.00
# Analysts10
Ownership
Shares Out.73.27M
Float60.52M
Insiders6.22%
Institutions111.84%
Short Interest
Short Ratio9.4d
Short % Float16.03%
Short % Out.11.13%
Shares Short8.15M
Short (prev mo.)8.53M
Technical
SMA 5052.36 (+14.2%)
SMA 20035.44 (+68.8%)
Beta0.24
S&P 52W Chg18.16%
Avg Vol (30d)804.16K
Avg Vol (10d)758.42K
Technical Indicators
RSI (14)65.3
MACD2.3029
MACD Signal2.5264
MACD Hist.-0.2235
BB Upper63.32 USD
BB Middle57.27 USD
BB Lower51.21 USD
BB Width21.13%
ATR (14)2.528 USD
Vol Ratio (20d)0.67x